. Author manuscript; available in PMC: 2012 Dec 19.

Published in final edited form as: Eur J Appl Physiol. 2009 Apr 18;106(4):621–627. doi: 10.1007/s00421-009-1051-4

Table 1.

Subject characteristics for the chronic heart failure and healthy control group

	HF	Control
Age (year)	53 ± 14	51 ± 18
Male/female	7/3	7/3
BMI (kg m⁻²)	26.0 ± 4.7	24.5 ± 2.4
MAP (mmHg)	76 ± 9.2	84 ± 9.2
NYHA functional classes	2.0 ± 0.9
Q (l min⁻¹)	4.3 ± 1.1	4.5 ± 0.5
Conductance (ml min⁻¹ mmHg⁻¹)	54 ± 15	53 ± 14
Resting EF (%)	23 ± 8
LLCT (s)	53.6 ± 8.2	55.3 ± 10.9
Cardiovascular medications
ACE/A-II receptor blocker	10/10
Digoxin	6/10
Beta blocker	9/10
Diuretic	7/10

Results are mean ± SD

HF chronic heart failure group, BMI body mass index, MAP mean arterial pressure, NYHA New York Heart Association Classification, Q cardiac output, EF ejection fraction, LLCT lung-to-lung circulation time, ACE angiotensin-converting enzyme inhibitor, A-II angiotensin II